Joseph Garcia
Joseph focuses on corporate finance and mergers and acquisitions. He advises public and private companies and financial institutions. Joseph has extensive expertise in advising on domestic and cross border transactions, including public offerings, take-over and issuer bids, private equity and venture capital financings, private and public mergers and acquisitions, and as independent counsel to boards of directors. He has recently advised AbCellera, Zymeworks, Xenon, enGene, NervGen, Orpyx, Eupraxia, Alpha-9, Notch, adMare BioInnovations and Essa Pharma. Joseph is a director emeritus of LifeSciences BC. Joseph is a former director of the Canadian Glycomics Network (National Centre of Excellence) and Genome BC., and a member of the BIOTECanada Legal Affairs Advisory Board. He is a director of Science World and a member of the Canadian Bar Association. · Blake, Cassels & Graydon LLP
About
Joseph focuses on corporate finance and mergers and acquisitions, advising public and private companies and financial institutions on domestic and cross-border transactions including public offerings, take-over and issuer bids, private equity and venture capital financings, and private and public M&A. He has acted as independent counsel to boards and has advised companies such as AbCellera, Zymeworks, Xenon, enGene, NervGen, Orpyx, Eupraxia, Alpha-9, Notch, adMare BioInnovations and Essa Pharma; he is director emeritus of LifeSciences BC, a former director of the Canadian Glycomics Network and Genome BC, a member of the BIOTECanada Legal Affairs Advisory Board, a director of Science World and a member of the Canadian Bar Association.